Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection
Among women, breast cancer (BC) is not only the most common cancer worldwide but also the leading cause of cancer death. Only 5–10% of breast cancer cases are attributed to inherited mutations (BRCA1, BRCA2, and other breast cancer susceptibility genes). Breast cancer incidence has been rising parti...
Main Authors: | Farah J. Nassar, Ghada Chamandi, Mohamad Ali Tfaily, Nathalie Khoueiry Zgheib, Rihab Nasr |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00028/full |
Similar Items
-
Liquid Biopsy in Neurological Diseases
by: Sunny Malhotra, et al.
Published: (2023-07-01) -
BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01) -
Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01) -
Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01) -
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)